$NEGG
Newegg Commerce, Inc. Stock $negg

$negg Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 20-F Financial Statement

#000121390023033334 Filed on April 27, 2023

Income Statement

Concept	2022 Q4	2022	2021 Q4
Revenue	$480.6M	$1.720B	$628.5M
YoY Change	-23.53%	-27.6%	3246051.86%
Cost Of Revenue	$420.9M	$224.3M	$549.1M
YoY Change	-23.35%	-89.06%	830874.58%
Gross Profit	$59.70M	$216.6M	$79.35M
YoY Change	-24.76%	-33.55%	-169935.19%
Gross Profit Margin	12.42%	12.59%	12.63%
Selling, General & Admin	$67.74M	$266.2M	$76.28M
YoY Change	-11.2%	-8.99%	5295.52%
% of Gross Profit	113.46%	122.87%	96.14%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.077M	$11.02M	$2.545M
YoY Change	20.9%	1.69%	3332.23%
% of Gross Profit	5.15%	5.09%	3.21%
Operating Expenses	$67.74M	$266.2M	$76.28M
YoY Change	-11.2%	-8.99%	5295.52%
Operating Profit	-$8.037M	-$49.54M	$3.063M
YoY Change	-362.39%	-247.82%	-309.71%
Interest Expense	$436.0K	$685.0K	-$6.582M
YoY Change	-106.62%	-110.01%	-4230.27%
% of Operating Profit			-214.89%
Other Income/Expense, Net	$536.0K	$5.280M	$1.302M
YoY Change	-58.83%	200.34%	156767.47%
Pretax Income	-$9.346M	-$43.33M	-$2.217M
YoY Change	321.56%	-242.21%	43.43%
Income Tax	$20.73M	$14.10M	-$8.434M
% Of Pretax Income
Net Earnings	-$30.07M	$57.43M	$6.217M
YoY Change	-583.71%	58.37%	-502.21%
Net Earnings / Revenue	-6.26%	3.34%	0.99%
Basic Earnings Per Share		-$0.15
Diluted Earnings Per Share	-$0.08	-$0.15	$14.71K
COMMON SHARES
Basic Shares Outstanding	376.7M shares	373.1M shares
Diluted Shares Outstanding		373.1M shares

Balance Sheet

Concept	2022 Q4	2022	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$122.6M	$122.6M	$99.99M
YoY Change	22.57%	22.57%	5405.68%
Cash & Equivalents	$122.6M	$122.6M	$99.99M
Short-Term Investments
Other Short-Term Assets	$5.611M	$23.56M	$30.21M
YoY Change	-81.43%	-22.03%	683.42%
Inventory	$156.0M	$156.0M	$245.1M
Prepaid Expenses	$17.00M		$17.95M
Receivables	$83.52M	$83.52M	$62.37M
Other Receivables	$5.173M	$5.173M	$1.303M
Total Short-Term Assets	$390.8M	$390.8M	$439.0M
YoY Change	-10.97%	-10.97%	7249.67%
LONG-TERM ASSETS
Property, Plant & Equipment	$45.08M	$129.2M	$144.7M
YoY Change	-68.86%	-10.71%	191215.27%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$11.25M	$11.25M	$17.28M
YoY Change	-34.9%	-34.9%
Other Assets	$9.919M	$10.79M	$25.61M
YoY Change	-61.27%	-57.88%
Total Long-Term Assets	$151.3M	$151.3M	$187.6M
YoY Change	-19.37%	-19.37%	247911.9%
TOTAL ASSETS
Total Short-Term Assets	$390.8M	$390.8M	$439.0M
Total Long-Term Assets	$151.3M	$151.3M	$187.6M
Total Assets	$542.1M	$542.1M	$626.6M
YoY Change	-13.48%	-13.48%	10259.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$207.1M	$207.1M	$220.8M
YoY Change	-6.17%	-6.17%	1186229.93%
Accrued Expenses	$51.00M	$65.27M	$89.29M
YoY Change	-42.88%	-26.9%	10206.93%
Deferred Revenue	$31.03M
YoY Change
Short-Term Debt	$6.056M	$6.056M	$6.182M
YoY Change	-2.04%	-2.04%	246.51%
Long-Term Debt Due	$269.0K	$269.0K	$293.0K
YoY Change	-8.19%	-8.19%
Total Short-Term Liabilities	$309.8M	$309.8M	$356.3M
YoY Change	-13.06%	-13.06%	13013.52%
LONG-TERM LIABILITIES
Long-Term Debt	$1.404M	$1.404M	$1.843M
YoY Change	-23.82%	-23.82%
Other Long-Term Liabilities	$124.0K	$75.70M	$86.15M
YoY Change	-99.86%	-12.13%	16509.21%
Total Long-Term Liabilities	$1.528M	$77.11M	$87.99M
YoY Change	-98.26%	-12.37%	16864.54%
TOTAL LIABILITIES
Total Short-Term Liabilities	$309.8M	$309.8M	$356.3M
Total Long-Term Liabilities	$1.528M	$77.11M	$87.99M
Total Liabilities	$386.9M	$386.9M	$444.3M
YoY Change	-12.93%	-12.93%	13630.8%
SHAREHOLDERS EQUITY
Retained Earnings	-$71.71M		-$14.28M
YoY Change	402.16%
Common Stock	$241.0M		$205.7M
YoY Change	17.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$155.2M	$155.2M	$182.3M
YoY Change
Total Liabilities & Shareholders Equity	$542.1M	$542.1M	$626.6M
YoY Change	-13.48%	-13.48%	10259.84%

Cashflow Statement

Concept	2022 Q4	2022	2021 Q4
OPERATING ACTIVITIES
Net Income	-$30.07M	$57.43M	$6.217M
YoY Change	-583.71%	58.37%	-502.21%
Depreciation, Depletion And Amortization	$3.077M	$11.02M	$2.545M
YoY Change	20.9%	1.69%	3332.23%
Cash From Operating Activities	$41.77M	$20.48M	-$13.50M
YoY Change	-409.44%	-138.43%	1903.89%
INVESTING ACTIVITIES
Capital Expenditures	$580.0K	$9.190M	-$3.748M
YoY Change	-115.47%	-166.41%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$5.420M	$1.000K
YoY Change	-100.0%	541900.0%	-142.55%
Cash From Investing Activities	-$580.0K	-$3.770M	-$3.747M
YoY Change	-84.52%	-72.76%	159346.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00	$265.0K
YoY Change		-100.0%
Debt Paid & Issued, Net		$274.0K
YoY Change		-3.86%
Cash From Financing Activities	-1.063M	$1.548M	206.0K
YoY Change	-616.02%	-87.85%	-154.56%
NET CHANGE
Cash From Operating Activities	41.77M	$20.48M	-13.50M
Cash From Investing Activities	-580.0K	-$3.770M	-3.747M
Cash From Financing Activities	-1.063M	$1.548M	206.0K
Net Change In Cash	40.13M	$19.18M	-17.04M
YoY Change	-335.49%	-135.26%	1517.33%
FREE CASH FLOW
Cash From Operating Activities	$41.77M	$20.48M	-$13.50M
Capital Expenditures	$580.0K	$9.190M	-$3.748M
Free Cash Flow	$41.19M	$11.29M	-$9.751M
YoY Change	-522.43%	-128.62%	1347.51%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation		usd
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation		usd
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1		usd
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther		pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther		pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther		pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Foreign EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign		pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Foreign EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign		pure
CY2022	negg	Effective Income Tax Reconcillation Global Intangible Lowtaxed Income EffectiveIncomeTaxReconcillationGlobalIntangibleLowtaxedIncome		pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
CY2005Q3	negg	Incentive Stock Options Granted Period IncentiveStockOptionsGrantedPeriod	P5Y
CY2022	us-gaap	Line Of Credit Facility Expiration Period LineOfCreditFacilityExpirationPeriod	P4Y
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
CY2020	negg	Restricted Stock Units RestrictedStockUnits		shares
CY2020	negg	Warrants Warrants		shares
CY2022Q4	us-gaap	Inventory Net InventoryNet	156016000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	245078000	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	5173000	usd
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3197000	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	1669000	usd
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1303000	usd
CY2022	dei	Document Type DocumentType	20-F
CY2022	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-34661
CY2022	dei	Entity Registrant Name EntityRegistrantName	Newegg Commerce, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D8
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	17560 Rowland Street
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	City of Industry
CY2022	dei	Entity Address Country EntityAddressCountry	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	91748
CY2022	dei	Security12b Title Security12bTitle	Common Shares, par value $0.021848
CY2022	dei	Trading Symbol TradingSymbol	NEGG
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	376660069	shares
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022	dei	Auditor Firm AuditorFirmId	243
CY2022	dei	Auditor Name AuditorName	BDO USA, LLP
CY2022	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	122559000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99993000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	947000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	4337000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	83517000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	62373000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	16999000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	17946000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	5611000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	7931000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	390822000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	438961000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45075000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	50149000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	868000	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	13367000	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	11250000	usd
CY2021Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	15000000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	84161000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	94581000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9919000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	14524000	usd
CY2022Q4	us-gaap	Assets Assets	542095000	usd
CY2021Q4	us-gaap	Assets Assets	626582000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	207147000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	220776000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	51003000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	74689000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	31028000	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	39767000	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	6056000	usd
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	6182000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	269000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	293000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14265000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14603000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	309768000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	356310000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1404000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1843000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	739000	usd
CY2021Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	696000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	74838000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	84307000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	124000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1144000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	386873000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	444300000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.021848
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.021848
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	376660000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	376660000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	369719000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	369719000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	8230000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	8078000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	232776000	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	197613000	usd
CY2022Q4	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	15189000	usd
CY2021Q4	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	15189000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1114000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	6060000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-71709000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14280000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	155222000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	182282000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	542095000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	626582000	usd
CY2022	us-gaap	Revenues Revenues	1720273000	usd
CY2021	us-gaap	Revenues Revenues	2376225000	usd
CY2020	us-gaap	Revenues Revenues	2114872000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1503647000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2050249000	usd
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1841243000	usd
CY2022	us-gaap	Gross Profit GrossProfit	216626000	usd
CY2021	us-gaap	Gross Profit GrossProfit	325976000	usd
CY2020	us-gaap	Gross Profit GrossProfit	273629000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	266164000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	292464000	usd
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	250239000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-49538000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	33512000	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	23390000	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	1164000	usd
CY2021	us-gaap	Interest Income Other InterestIncomeOther	1079000	usd
CY2020	us-gaap	Interest Income Other InterestIncomeOther	1124000	usd
CY2022	us-gaap	Interest Expense InterestExpense	685000	usd
CY2021	us-gaap	Interest Expense InterestExpense	612000	usd
CY2020	us-gaap	Interest Expense InterestExpense	664000	usd
CY2022	us-gaap	Other Income OtherIncome	5280000	usd
CY2021	us-gaap	Other Income OtherIncome	1758000	usd
CY2020	us-gaap	Other Income OtherIncome	5320000	usd
CY2022	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	2281000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-7374000	usd
CY2021	negg	Interest On Notes Receivable InterestOnNotesReceivable	-3000	usd
CY2021	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	2043000	usd
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1063000	usd
CY2021	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	61000	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-43328000	usd
CY2021	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	30467000	usd
CY2020	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	32367000	usd
CY2022	negg	Provision Forbenefit From Income Taxes ProvisionForbenefitFromIncomeTaxes	14101000	usd
CY2021	negg	Provision Forbenefit From Income Taxes ProvisionForbenefitFromIncomeTaxes	-5795000	usd
CY2020	negg	Provision Forbenefit From Income Taxes ProvisionForbenefitFromIncomeTaxes	1941000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-57429000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	36262000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	30426000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.1
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	373067000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	366651000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	363326000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	373067000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	432250000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	385013000	shares
CY2022	us-gaap	Net Income Loss NetIncomeLoss	57429000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-36262000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-30426000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	4946000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3003000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3562000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	-62375000	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	39265000	usd
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	33988000	usd
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	92044000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-30426000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3562000	usd
CY2020	negg	Interest On Notes Receivable InterestOnNotesReceivable	-157000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1622000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	127497000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-36262000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3003000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	270000	usd
CY2021	negg	Recapitalization Transaction Net RecapitalizationTransactionNet	8430000	usd
CY2021	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	538000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	6285000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	182282000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	57429000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4946000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2890000	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-1514000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	33939000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	155222000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-57429000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	36262000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	30426000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11021000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10838000	usd
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9091000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	697000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1718000	usd
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7288000	usd
CY2022	negg	Recovery Of Related Party Receivable RecoveryOfRelatedPartyReceivable	50000	usd
CY2021	negg	Recovery Of Related Party Receivable RecoveryOfRelatedPartyReceivable	335000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	9537000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	8274000	usd
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	4218000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	33939000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	6285000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1622000	usd
CY2022	negg	Impairment Of Equity Method Investments ImpairmentOfEquityMethodInvestments	2281000	usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-7374000	usd
CY2020	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	3197000	usd
CY2022	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	1669000	usd
CY2022	us-gaap	Provision For Other Losses ProvisionForOtherLosses	-1063000	usd
CY2021	us-gaap	Provision For Other Losses ProvisionForOtherLosses	-61000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	-431000	usd
CY2021	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	-83000	usd
CY2020	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	-246000	usd
CY2021	negg	Gain From Disposal Of Subsidiary GainFromDisposalOfSubsidiary	2043000	usd
CY2022	negg	Unrealizedgain Loss On Marketable Securities UnrealizedgainLossOnMarketableSecurities	-55000	usd
CY2021	negg	Unrealizedgain Loss On Marketable Securities UnrealizedgainLossOnMarketableSecurities	-101000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	12499000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-12698000	usd
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	372000	usd
CY2022	negg	Provision For Accounts Receivable ProvisionForAccountsReceivable	-21969000	usd
CY2021	negg	Provision For Accounts Receivable ProvisionForAccountsReceivable	788000	usd
CY2020	negg	Provision For Accounts Receivable ProvisionForAccountsReceivable	-14054000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-78766000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	70830000	usd
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	76240000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-905000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	2152000	usd
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	7516000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-9982000	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	50919000	usd
CY2020	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	10532000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-14063000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-20072000	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	76337000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-34449000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	41547000	usd
CY2020	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	44636000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-8941000	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-7443000	usd
CY2020	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	21817000	usd
CY2021	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	3000	usd
CY2020	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	2000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	20480000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-53286000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	84512000	usd
CY2020	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	788000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9190000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13839000	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6156000	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1000	usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1000	usd
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	132000	usd
CY2022	negg	Sale Of Equity Method Investment SaleOfEquityMethodInvestment	-5419000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3770000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13838000	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5236000	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	46188000	usd
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	787000	usd
CY2020	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	20000000	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	45742000	usd
CY2020	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	21467000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	274000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	285000	usd
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	265000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11426000	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	538000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2890000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	270000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1514000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1548000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12736000	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1732000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	918000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	972000	usd
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-345000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	19176000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-53416000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	77199000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	104330000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	157746000	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	80547000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	123506000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	104330000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	157746000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	558000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	268000	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	270000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	4963000	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	6374000	usd
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	261000	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	723000	usd
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	677000	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	7517000	usd
CY2021	us-gaap	Stock Issued1 StockIssued1	60672000	usd
CY2020	us-gaap	Stock Issued1 StockIssued1	16910000	usd
CY2016Q3	us-gaap	Stockholders Equity Other StockholdersEquityOther	91900000	usd
CY2021Q2	negg	Aggregate Common Shares AggregateCommonShares	363325542	shares
CY2021Q2	negg	Exchange Ratio ExchangeRatio	5.8417	pure
CY2021Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	0	cny
CY2021Q2	negg	Exchange Ratio ExchangeRatio	5.8417	pure
CY2021	us-gaap	Gain Loss Recognized On Assets Transferred To Separate Account GainLossRecognizedOnAssetsTransferredToSeparateAccount	2000000	usd
CY2021	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	0	usd
CY2021Q4	us-gaap	Carrying Value Of Securities Sold Under Repurchase Agreements And Deposits Received For Securities Loaned CarryingValueOfSecuritiesSoldUnderRepurchaseAgreementsAndDepositsReceivedForSecuritiesLoaned	2000000	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	36600000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><b>b. <i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The preparation of the Company’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect amounts reported in the consolidated financial statements and accompanying notes. Estimates are used for, but not limited to, revenue recognition, incentives earned from vendors, allowance for credit losses, investment valuation, valuation allowance for deferred tax assets, and stock-based compensation. Actual results could differ from such estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt"> </p>
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><b>c. <i>Reclassifications</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Certain prior period amounts have been reclassified to conform to the current period presentation. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt"><b><i> </i></b></p>
CY2022Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	13000000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	14300000	usd
CY2022Q4	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	900000	usd
CY2021Q4	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	4300000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	122559000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99993000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	947000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	4337000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	123506000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	104330000	usd
CY2021	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	43700000	usd
CY2022Q4	us-gaap	Inventory Net Of Allowances Customer Advances And Progress Billings InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings	5500000	usd
CY2021Q4	us-gaap	Inventory Net Of Allowances Customer Advances And Progress Billings InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings	6800000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	32800000	usd
CY2022Q4	negg	Product Sales Percentage ProductSalesPercentage	0.94	pure
CY2021Q4	negg	Product Sales Percentage ProductSalesPercentage	0.94	pure
CY2020Q4	negg	Product Sales Percentage ProductSalesPercentage	0.94	pure
CY2022	us-gaap	Regulatory Asset Amortization Period RegulatoryAssetAmortizationPeriod	P1Y
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	31000000	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	39800000	usd
CY2022	negg	Shipping And Handling Revenue ShippingAndHandlingRevenue	15300000	usd
CY2021	negg	Shipping And Handling Revenue ShippingAndHandlingRevenue	25300000	usd
CY2020	negg	Shipping And Handling Revenue ShippingAndHandlingRevenue	33700000	usd
CY2022	negg	Shipping And Handling Costs ShippingAndHandlingCosts	49200000	usd
CY2021	negg	Shipping And Handling Costs ShippingAndHandlingCosts	64700000	usd
CY2020	negg	Shipping And Handling Costs ShippingAndHandlingCosts	80100000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	224300000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	140000000	usd
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	135800000	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1300000	usd
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1500000	usd
CY2020	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1100000	usd
CY2022	us-gaap	Accounts Receivable Sale AccountsReceivableSale	63600000	usd
CY2021	us-gaap	Accounts Receivable Sale AccountsReceivableSale	41500000	usd
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	600000	usd
CY2021Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	600000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	14700000	usd
CY2022Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	2000000	usd
CY2020	us-gaap	Advertising Expense AdvertisingExpense	29000000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Deductions Medicare Prescription Drug Benefit EffectiveIncomeTaxRateReconciliationDeductionsMedicarePrescriptionDrugBenefit	0.50	pure
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><b><i>w. Concentration of Credit Risk and Significant Customers and Vendors</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company maintains its cash and cash equivalents in bank deposit accounts which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts and does not believe it is exposed to any significant credit risk from cash and cash equivalents.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">For the years ended December 31, 2022, 2021 and 2020, the Company had no individual customers that accounted for greater than 10% of net sales.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company purchases its products on credit terms from vendors located primarily in the United States. For the years ended December 31, 2022, 2021 and 2020, the Company’s cumulative annual purchases from four vendors, three vendors and one vendor, respectively, exceeded 10% of total purchases. The majority of products that the Company sells are available through multiple channels.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company has receivables due from vendors related to its advertising and promotional programs and receivables due from business customers with credit terms. As of December 31, 2022, receivables from two vendors exceeded 10% of net receivables. As of December 31, 2021, no receivables from any vendor exceeded 10% of net receivables. As of December 31, 2022 and 2021, no receivables from business customers with credit terms exceeded 10% of net receivables.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt"><b><i> </i></b></p>
CY2022Q4	negg	Net Sales Percentage NetSalesPercentage	0.10	pure
CY2021Q4	negg	Net Sales Percentage NetSalesPercentage	0.10	pure
CY2020Q4	negg	Net Sales Percentage NetSalesPercentage	0.10	pure
CY2022Q4	us-gaap	Investment Sold Not Yet Purchased Percent Of Net Assets InvestmentSoldNotYetPurchasedPercentOfNetAssets	0.10	pure
CY2022Q4	srt	Financing Receivable Nonaccrual To Outstanding Percent FinancingReceivableNonaccrualToOutstandingPercent	0.10	pure
CY2021Q4	srt	Financing Receivable Nonaccrual To Outstanding Percent FinancingReceivableNonaccrualToOutstandingPercent	0.10	pure
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	132400000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	139853000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	87325000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	89704000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45075000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	50149000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11000000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10800000	usd
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9100000	usd
CY2018Q2	negg	Mountains Investment Percentage MountainsInvestmentPercentage	0.50	pure
CY2018	negg	Initial Investment InitialInvestment	43000000	usd
CY2018Q4	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	7000000	usd
CY2019Q2	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	7000000	usd
CY2018	negg	Contingent Consideration Description ContingentConsiderationDescription	The Company recorded an estimate of contingent consideration payable of $7.0 million as of the acquisition date.
CY2021	negg	Carrying Value Investment CarryingValueInvestment	2300000	usd
CY2021Q4	negg	Ownership Percentage OwnershipPercentage	0.04	pure
CY2022Q4	us-gaap	Percentage Of Fifo Inventory PercentageOfFIFOInventory	1	pure
CY2022	us-gaap	Related Party Costs RelatedPartyCosts	700000	usd
CY2022	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	2300000	usd
CY2018Q3	negg	Contingent Consideration ContingentConsideration	15000000	usd
CY2022Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	11149200	shares
CY2022Q2	negg	Stock Repurchased Per Share StockRepurchasedPerShare	0.48605796
CY2022Q2	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	1700000	usd
CY2022Q4	us-gaap	Investments Investments	11300000	usd
CY2021Q4	us-gaap	Investments Investments	15000000	usd
CY2022Q4	us-gaap	Financing Receivable Revolving FinancingReceivableRevolving	100000000	usd
CY2015Q3	us-gaap	Lines Of Credit Fair Value Disclosure LinesOfCreditFairValueDisclosure	5000000	usd
CY2022Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	17250000	usd
CY2021Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	24512000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	13474000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	21132000	usd
CY2022Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	8664000	usd
CY2021Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	9102000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2522000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	6625000	usd
CY2022Q4	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	2513000	usd
CY2021Q4	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	3392000	usd
CY2022Q4	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	1996000	usd
CY2021Q4	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	3338000	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	1374000	usd
CY2021Q4	us-gaap	Inventory Adjustments InventoryAdjustments	2647000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3210000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3941000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	51003000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	74689000	usd
CY2018Q3	us-gaap	Lines Of Credit Fair Value Disclosure LinesOfCreditFairValueDisclosure	100000000	usd
CY2018Q3	us-gaap	Long Term Debt Maturity Date LongTermDebtMaturityDate	2021-07-27
CY2018Q3	negg	Loan Agreement Increased LoanAgreementIncreased	140000000	usd
CY2018Q3	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	25000000	usd
CY2018Q3	negg	Bank Funding Rate BankFundingRate	0.005	pure
CY2018Q3	negg	Libor Plus LiborPlus	0.01	pure
CY2018Q3	us-gaap	Line Of Credit Facility Unused Capacity Commitment Fee Percentage LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage	0.0025	pure
CY2018Q3	negg	Revolving Advance Amount RevolvingAdvanceAmount	0.004	pure
CY2021Q3	us-gaap	Lines Of Credit Fair Value Disclosure LinesOfCreditFairValueDisclosure	100000000	usd
CY2021Q3	us-gaap	Long Term Debt Maturity Date LongTermDebtMaturityDate	2024-08-20
CY2021Q3	negg	Loan Agreement Increased LoanAgreementIncreased	150000000	usd
CY2021Q3	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	30000000	usd
CY2021Q3	negg	Bank Funding Rate BankFundingRate	0.005	pure
CY2021Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.01	pure
CY2022	us-gaap	Line Of Credit Facility Unused Capacity Commitment Fee Percentage LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage	0.0015	pure
CY2015Q3	us-gaap	Lines Of Credit Fair Value Disclosure LinesOfCreditFairValueDisclosure	150000000	twd
CY2015Q3	us-gaap	Long Term Debt Maturity Date LongTermDebtMaturityDate	2023-12-15
CY2015Q3	us-gaap	Federal Home Loan Bank Advances Branch Of Fhlb Bank Interest Rate FederalHomeLoanBankAdvancesBranchOfFHLBBankInterestRate	0.0078	pure
CY2015Q3	negg	Savings Account Plus SavingsAccountPlus	0.0162	pure
CY2022Q4	us-gaap	Investment Interest Rate InvestmentInterestRate	0.0212	pure
CY2021Q2	us-gaap	Line Of Credit Facility Periodic Payment LineOfCreditFacilityPeriodicPayment	800000	usd
CY2021Q2	us-gaap	Line Of Credit Facility Periodic Payment LineOfCreditFacilityPeriodicPayment	5000000	cny
CY2021Q2	us-gaap	Debt Securities Held To Maturity Credit Quality Indicator Date Updated DebtSecuritiesHeldToMaturityCreditQualityIndicatorDateUpdated	2022-06-15
CY2021Q2	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.005	pure
CY2022Q2	us-gaap	Line Of Credit Facility Periodic Payment LineOfCreditFacilityPeriodicPayment	1200000	usd
CY2022Q2	us-gaap	Line Of Credit Facility Periodic Payment LineOfCreditFacilityPeriodicPayment	8000000	cny
CY2022Q2	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.003	pure
CY2022Q4	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.04	pure
CY2021Q4	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.0435	pure
CY2022	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	1200000	usd
CY2021	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	800000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	1673000	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	2136000	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	269000	usd
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	293000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1404000	usd
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1843000	usd
CY2022	negg	Term Loan Description TermLoanDescription	In 2013, the Company entered into a term loan agreement with a financial institution for $4.1 million with a maturity date of November 26, 2028 (the “Term Loan”).
CY2022	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0195	pure
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	269000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	275000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	280000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	286000	usd
CY2022Q4	negg	Long Term Debt Maturities Repayments Of Principal In Year Six LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix	291000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	272000	usd
CY2022Q4	negg	Total Long Term Debt TotalLongTermDebt	1673000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	25300000	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	20100000	usd
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	16500000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	22000000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	17700000	usd
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	14500000	usd
CY2022Q4	negg	Operating Leases Right Of Use Asset OperatingLeasesRightOfUseAsset	84200000	usd
CY2021Q4	negg	Operating Leases Right Of Use Asset OperatingLeasesRightOfUseAsset	94600000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	89100000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	98900000	usd
CY2022Q4	negg	Operating Leases Liability Noncurrent OperatingLeasesLiabilityNoncurrent	74800000	usd
CY2021Q4	negg	Operating Leases Liability Noncurrent OperatingLeasesLiabilityNoncurrent	84300000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y11M26D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.038	pure
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y10M9D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.038	pure
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	17996000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	16887000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	16538000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	14307000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	14593000	usd
CY2022Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	19685000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	100006000	usd
CY2022Q4	negg	Finance Lease Liability Imputed Interest FinanceLeaseLiabilityImputedInterest	10903000	usd
CY2022Q4	negg	Finance Lease Liability Present Value Of Lease Liabilitie FinanceLeaseLiabilityPresentValueOfLeaseLiabilitie	89103000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-68000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2536000	usd
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	21000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	268000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	795000	usd
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	133000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1402000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	3572000	usd
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1415000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1602000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	6903000	usd
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1569000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	8882000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-9013000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	3552000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3472000	usd
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-118000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	65000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-213000	usd
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	490000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	12499000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-12698000	usd
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	372000	usd
CY2022	negg	Provision Forbenefits From Income Taxes ProvisionForbenefitsFromIncomeTaxes	14101000	usd
CY2021	negg	Provision Forbenefits From Income Taxes ProvisionForbenefitsFromIncomeTaxes	-5795000	usd
CY2020	negg	Provision Forbenefits From Income Taxes ProvisionForbenefitsFromIncomeTaxes	1941000	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-43328000	usd
CY2021	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	30467000	usd
CY2020	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	32367000	usd
CY2022	negg	Amortize Period AmortizePeriod	P5Y
CY2022	negg	Capitalized And Amortized Term CapitalizedAndAmortizedTerm	P5Y
CY2022	negg	Expenditures Attributable To Foreign Research ExpendituresAttributableToForeignResearch	P15Y
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	2600000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1606000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1563000	usd
CY2021Q4	negg	Warrants And Rights Outstanding Fair Value WarrantsAndRightsOutstandingFairValue	1091000	usd
CY2021Q4	negg	Warrants And Rights Outstanding Fair Value WarrantsAndRightsOutstandingFairValue	1091000	usd
CY2022	negg	Fair Value Of Issued Warrants FairValueOfIssuedWarrants	-1063000	usd
CY2022Q4	negg	Warrants And Rights Outstanding Fair Value WarrantsAndRightsOutstandingFairValue	28000	usd
CY2022Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	5123000	usd
CY2021Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	4295000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	2807000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	4413000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	3062000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	5903000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	20668000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	22203000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts	2601000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	1965000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	2144000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9921000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6102000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	46147000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	45060000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	24128000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5543000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	22019000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	39517000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	864000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	798000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-773000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-621000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	19514000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	21212000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	3219000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	300000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	21151000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	26150000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	868000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	13367000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	24100000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	5500000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	19600000	usd
CY2022	negg	Income Tax Effects Allocated Directly To Equity Cumulative Effect Of Change In Accounting Principles IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciples	0.80	pure
CY2021Q1	negg	Income Tax Effects Allocated Directly To Equity Cumulative Effect Of Change In Accounting Principle Afterwards IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrincipleAfterwards	0.80	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0248	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0685	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0004	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.003	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.0048	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.0017	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.008	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0003	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.1088	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0074	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0007	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.0157	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	-0.0204	pure
CY2020	negg	Effective Income Tax Reconcillation Global Intangible Lowtaxed Income EffectiveIncomeTaxReconcillationGlobalIntangibleLowtaxedIncome	0.0236	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	-0.0074	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	0.0215	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	0.0112	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.001	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.0001	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.0343	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.0127	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.3208	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.1902	pure
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.06	pure
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	1600000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1563000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	850000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	43000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	713000	usd
CY2022Q4	negg	Common Stock Par Value CommonStockParValue	0.021848
CY2022	us-gaap	Common Stock Voting Rights CommonStockVotingRights	Each share of common stock is entitled to one vote.
CY2022Q4	negg	Warrant Issued WarrantIssued	125000	shares
CY2022	negg	Warrant Outstanding WarrantOutstanding	125000	shares
CY2022Q4	us-gaap	Share Price SharePrice	1.31
CY2021Q4	us-gaap	Share Price SharePrice	10.37
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	17.6
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	17.6
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0418	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0116	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y3M25D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y3M25D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.969	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.4733	pure
CY2021Q2	negg	Warrants And Rights Outstanding Fair Value WarrantsAndRightsOutstandingFairValue	1152000	usd
	negg	Fair Value Of Issued Warrants FairValueOfIssuedWarrants	-61000	usd
CY2005Q3	negg	Vested In Period VestedInPeriod	P4Y
CY2005Q3	negg	Exercisable Period ExercisablePeriod	P10Y
CY2005Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.10	pure
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	15201143	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.43
CY2019Q4	negg	Average Remaining Contractual Terms Outstanding Beginning Balance AverageRemainingContractualTermsOutstandingBeginningBalance	P4Y9M18D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	1723000	usd
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	51921030	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	85347	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.73
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	67036826	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.6
CY2020Q4	negg	Average Remaining Contractual Terms Outstanding Beginning Balance AverageRemainingContractualTermsOutstandingBeginningBalance	P8Y2M8D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	51754000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	1457517	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	178916	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.73
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	65400393	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.6
CY2021Q4	negg	Average Remaining Contractual Terms Outstanding Beginning Balance AverageRemainingContractualTermsOutstandingBeginningBalance	P7Y3M18D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	639131000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	6305365	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.61
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	59635	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.73
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	59035393	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.6
CY2022Q4	negg	Average Remaining Contractual Terms Outstanding Beginning Balance AverageRemainingContractualTermsOutstandingBeginningBalance	P6Y5M15D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	42143000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	59035393	shares
CY2022	negg	Weighted Average Exercise Price Vested And Expected WeightedAverageExercisePriceVestedAndExpected	0.6
CY2022	negg	Sharebased Compensation Arrangement By Sharebased Payment Award Options Average Remaining Contractual Terms Vested And Expected SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAverageRemainingContractualTermsVestedAndExpected	P6Y5M15D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	42143000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	37637243	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.57
CY2022	negg	Sharebased Compensation Arrangement By Sharebased Payment Award Options Average Remaining Contractual Terms Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAverageRemainingContractualTermsExercisable	P5Y10M24D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	27787000	usd
CY2022	negg	Stock Options Exercised StockOptionsExercised	6305365	shares
CY2022	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	4956468	shares
CY2022	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2900000	usd
CY2022	negg	Cashless Exercises Shares CashlessExercisesShares	1348897	shares
CY2022	negg	Cashless Exercises Net Shares CashlessExercisesNetShares	1059240	shares
CY2021	negg	Stock Options Exercised StockOptionsExercised	1457517	shares
CY2021	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	371527	shares
CY2021	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	300000	usd
CY2021	negg	Cashless Exercises Shares CashlessExercisesShares	1085990	shares
CY2021	negg	Cashless Exercises Net Shares CashlessExercisesNetShares	1048298	shares
CY2022	negg	Total Intrinsic Value Of Stock Options Exercised TotalIntrinsicValueOfStockOptionsExercised	24300000	usd
CY2021	negg	Total Intrinsic Value Of Stock Options Exercised TotalIntrinsicValueOfStockOptionsExercised	24200000	usd
CY2020	negg	Total Intrinsic Value Of Stock Options Exercised TotalIntrinsicValueOfStockOptionsExercised	0	usd
CY2022	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	3200000	usd
CY2021	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	3200000	usd
CY2020	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	1600000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	4600000	usd
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	7800000	usd
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y5M15D
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y5M15D
CY2020Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y5M15D
CY2021Q4	us-gaap	Common Unit Issued CommonUnitIssued	7374900	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	285000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	7040998	shares
CY2022	us-gaap	Deferred Compensation Arrangement With Individual Requisite Service Period1 DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1	P4Y
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	5560780	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	1386445	shares
CY2022	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	30800000	usd
CY2021	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	3100000	usd
CY2022Q4	negg	Unrecognized Compensation Costs Related To Restricted Stock Units UnrecognizedCompensationCostsRelatedToRestrictedStockUnits	82900000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-57429000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	36262000	usd
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	30426000	usd
CY2022	negg	Weighted Average Number Of Shares Outstandings Basic WeightedAverageNumberOfSharesOutstandingsBasic	373067000	shares
CY2021	negg	Weighted Average Number Of Shares Outstandings Basic WeightedAverageNumberOfSharesOutstandingsBasic	366651000	shares
CY2020	negg	Weighted Average Number Of Shares Outstandings Basic WeightedAverageNumberOfSharesOutstandingsBasic	363326000	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.1
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	373067000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	366651000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	363326000	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	65599000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	21687000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	373067000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	432250000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	385013000	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2022	negg	Stock Option StockOption	51845000	shares
CY2021	negg	Stock Option StockOption	54000	shares
CY2020	negg	Stock Option StockOption	4329000	shares
CY2022	negg	Restricted Stock Units RestrictedStockUnits	7084000	shares
CY2021	negg	Restricted Stock Units RestrictedStockUnits	7041000	shares
CY2022	negg	Warrants Warrants	125000	shares
CY2021	negg	Warrants Warrants	125000	shares
CY2020	negg	Gain From Disposal Of Subsidiary GainFromDisposalOfSubsidiary		usd
CY2020	negg	Unrealizedgain Loss On Marketable Securities UnrealizedgainLossOnMarketableSecurities		usd
CY2022	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates		usd
CY2022	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities		usd
CY2021	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities		usd
CY2021	negg	Sale Of Equity Method Investment SaleOfEquityMethodInvestment		usd
CY2022Q4	negg	Percentage Of Eligible Employees Compensation PercentageOfEligibleEmployeesCompensation	1	pure
CY2022	us-gaap	Defined Benefit Plan Benefit Obligation Contributions By Plan Participant DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant	1600000	usd
CY2021	us-gaap	Defined Benefit Plan Benefit Obligation Contributions By Plan Participant DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant	1900000	usd
CY2020	us-gaap	Defined Benefit Plan Benefit Obligation Contributions By Plan Participant DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant	1700000	usd
CY2022	negg	Percentage Of Contribution Vested PercentageOfContributionVested	1	pure
CY2019Q4	us-gaap	Loans Payable To Bank LoansPayableToBank	15000000	usd
CY2019Q4	us-gaap	Loans Held For Sale Maturity Date LoansHeldForSaleMaturityDate	2020-04-30
CY2019Q4	us-gaap	Federal Home Loan Bank Advances Interest Rate FederalHomeLoanBankAdvancesInterestRate	0.05	pure
CY2022Q4	us-gaap	Due To Affiliate Current DueToAffiliateCurrent	15000000	usd
CY2021Q4	us-gaap	Due To Affiliate Current DueToAffiliateCurrent	15000000	usd
CY2022	us-gaap	Interest Income Related Party InterestIncomeRelatedParty	800000	usd
CY2021	us-gaap	Interest Income Related Party InterestIncomeRelatedParty	800000	usd
CY2020	us-gaap	Interest Income Related Party InterestIncomeRelatedParty	700000	usd
CY2022Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	15000000	usd
CY2021Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	15000000	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	200000	usd
CY2021Q4	us-gaap	Interest Receivable InterestReceivable	200000	usd
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	pure
CY2022	negg	Net Sales From External Customers NetSalesFromExternalCustomers	1720273000	usd
CY2021	negg	Net Sales From External Customers NetSalesFromExternalCustomers	2376225000	usd
CY2020	negg	Net Sales From External Customers NetSalesFromExternalCustomers	2114872000	usd
CY2020	negg	Sale Of Equity Method Investment SaleOfEquityMethodInvestment		usd
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45075000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	50149000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2021	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment		usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2022	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary		usd
CY2020	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax		usd
CY2020	negg	Recovery Of Related Party Receivable RecoveryOfRelatedPartyReceivable		usd
CY2021	negg	Impairment Of Equity Method Investments ImpairmentOfEquityMethodInvestments		usd
CY2020	negg	Impairment Of Equity Method Investments ImpairmentOfEquityMethodInvestments		usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2021	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments		usd
CY2020	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments		usd
CY2020	us-gaap	Provision For Other Losses ProvisionForOtherLosses		usd
CY2022	negg	Gain From Disposal Of Subsidiary GainFromDisposalOfSubsidiary		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001474627

Files In Submission

Name	View Source	Status
negg-20221231_def.xml	Edgar Link	unprocessable
negg-20221231_cal.xml	Edgar Link	unprocessable
0001213900-23-033334-index-headers.html	Edgar Link	pending
0001213900-23-033334-index.html	Edgar Link	pending
0001213900-23-033334.txt	Edgar Link	pending
0001213900-23-033334-xbrl.zip	Edgar Link	pending
ex4-16_001.jpg	Edgar Link	pending
ex4-16_002.jpg	Edgar Link	pending
ex4-16_003.jpg	Edgar Link	pending
ex4-16_004.jpg	Edgar Link	pending
ex4-16_005.jpg	Edgar Link	pending
ex4-16_006.jpg	Edgar Link	pending
ex4-16_007.jpg	Edgar Link	pending
ex4-16_008.jpg	Edgar Link	pending
ex4-16_009.jpg	Edgar Link	pending
ex4-16_010.jpg	Edgar Link	pending
ex4-16_011.jpg	Edgar Link	pending
ex4-16_012.jpg	Edgar Link	pending
ex4-16_013.jpg	Edgar Link	pending
ex4-17_001.jpg	Edgar Link	pending
ex4-17_002.jpg	Edgar Link	pending
ex4-17_003.jpg	Edgar Link	pending
ex4-17_004.jpg	Edgar Link	pending
ex4-17_005.jpg	Edgar Link	pending
ex4-17_006.jpg	Edgar Link	pending
f20f2022ex12-1_newegg.htm	Edgar Link	pending
f20f2022ex12-2_newegg.htm	Edgar Link	pending
f20f2022ex13-1_newegg.htm	Edgar Link	pending
f20f2022ex13-2_newegg.htm	Edgar Link	pending
f20f2022ex15-1_newegg.htm	Edgar Link	pending
f20f2022ex2-2_newegg.htm	Edgar Link	pending
f20f2022ex4-16_newegg.htm	Edgar Link	pending
f20f2022ex4-17_newegg.htm	Edgar Link	pending
f20f2022ex4-6_newegg.htm	Edgar Link	pending
f20f2022ex4-8_newegg.htm	Edgar Link	pending
f20f2022ex8-1_newegg.htm	Edgar Link	pending
f20f2022_newegg.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
negg-20221231.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
f20f2022_newegg_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
negg-20221231_pre.xml	Edgar Link	unprocessable
negg-20221231_lab.xml	Edgar Link	unprocessable
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NEGG
Newegg Commerce, Inc. Stock $negg

2022 Q4 Form 20-F Financial Statement

#000121390023033334 Filed on April 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NEGG Newegg Commerce, Inc. Stock $negg

2022 Q4 Form 20-F Financial Statement

#000121390023033334 Filed on April 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NEGG
Newegg Commerce, Inc. Stock $negg